(marketscreener.com) MENLO PARK, Calif., June 23, 2020 /PRNewswire/ -- Ablacon, Inc., an Ajax Health-backed company, announced today the formation of its Scientific Advisory Board . The SAB will be composed of four internationally recognized thought leaders in the field of electrophysiology to guide Ablacon in its development of Ablamap®, a novel...https://www.marketscreener.com/news/Ablacon-Inc-Announces-the-Formation-of-Scientific-Advisory-Board--30810558/?utm_medium=RSS&utm_content=20200623
Ablacon is a Colorado-based AI firm that designs and develops an atrial fibrillation system to analyze and visualize electrographic flow within the cardiac chambers.